Jade Biosciences (JBIO) Operating Leases (2021 - 2026)

Jade Biosciences posted quarterly Operating Leases of $700000.0 for Q1 2026, down 3.31% on a QoQ basis from $724000.0 in Q4 2025.

Jade Biosciences (JBIO) has 6 years of Operating Leases data on file, last reported at $700000.0 in Q1 2026.

  • For the quarter ending Q1 2026, Operating Leases changed N/A year-over-year to $700000.0; the trailing twelve-month figure through Mar 2026 stood at $700000.0 (changed N/A YoY), and the FY2025 full-year result was $724000.0, changed N/A from the prior year.
  • Operating Leases for Q1 2026 stood at $700000.0, down from $724000.0 in the prior quarter.
  • Across five years, Operating Leases topped out at $1.2 million in Q2 2022 and bottomed at $81000.0 in Q3 2024.
  • The 5-year median for Operating Leases is $591000.0 (2023), against an average of $566733.3.
  • The widest annual swing landed in 2024, when Operating Leases plunged 77.37%; it then jumped 822.22% in 2025.
  • A 5-year view of Operating Leases shows it stood at $705000.0 in 2022, then slumped by 63.83% to $255000.0 in 2023, then tumbled by 68.24% to $81000.0 in 2024, then jumped by 793.83% to $724000.0 in 2025, then declined by 3.31% to $700000.0 in 2026.
  • The last three Operating Leases figures came in at $700000.0 (Q1 2026), $724000.0 (Q4 2025), and $747000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Quantum Biopharma 961,148.99 Bn 961,148.98 Bn -
2 Alterity Therapeutics 744,933.29 Bn 744,933.26 Bn -
3 Legend Biotech 2,540.00 Bn 2,539.71 Bn 242.10 Mn
4 Nanobiotix 2,199.85 Bn 2,199.78 Bn -
5 Akari Therapeutics 1,635.88 Bn 1,635.88 Bn -
6 Vertex Pharmaceuticals 111.32 Bn 104.07 Bn 2.59 Bn
7 Evaxion A 62.56 Bn 62.54 Bn -
8 Regeneron Pharmaceuticals 62.55 Bn 53.79 Bn 3.31 Bn
9 Alnylam Pharmaceuticals 39.57 Bn 36.56 Bn 959.66 Mn
10 Jade Biosciences 1.06 Bn 1.06 Bn -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2026 700,000.00
Dec 31, 2025 724,000.00
Sep 30, 2025 747,000.00
Jun 30, 2025 792,000.00
Sep 30, 2024 81,000.00
Jun 30, 2024 206,000.00
Mar 31, 2024 329,000.00
Dec 31, 2023 255,000.00
Sep 30, 2023 358,000.00
Jun 30, 2023 476,000.00
Mar 31, 2023 591,000.00
Dec 31, 2022 705,000.00
Sep 30, 2022 800,000.00
Jun 30, 2022 1.21 Mn
Mar 31, 2022 528,000.00
Dec 31, 2021 382,000.00
Sep 30, 2021 452,000.00